The rapid escalation of antimicrobial resistance (AMR) represents a critical threat to global public health, with drug-resistant infections projected to cause over 10 million deaths annually by 2050. There is an urgent need for the development of novel chemical entities that can bypass existing resistance mechanisms. N2, N4-Pyrimidine-2,4-diamines represent a privileged scaffold in medicinal chemistry due to their diverse biological activities and ease of structural modification.
In this study, a series of novel N2, N4-pyrimidine-2,4-diamine derivatives were designed and synthesized using a systematic structure-activity relationship (SAR) approach. The synthesis was achieved through a robust multi-step protocol involving cyclization followed by regioselective N-alkylation. The chemical structures of the synthesized compounds were rigorously characterized using Fourier-transform infrared spectroscopy (FT-IR), and structural derivatization of potent compound.
The synthetic methodology afforded the target derivatives in high yields ranging from 75% to 93%. In vitro antibacterial evaluation was conducted against representative Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) pathogens. Among the library, compound C5, characterized by a 3-nitrophenyl substitution at the pyrimidine core, emerged as the most potent lead. C5 exhibited minimum inhibitory concentrations (MIC) comparable to the reference fluoroquinolone antibiotic, Ciprofloxacin.
The SAR data suggests that the electronic nature of the phenyl ring substituents significantly influences antibacterial efficacy. These results validate the N2, N4-substituted pyrimidine-2,4- diamine framework as a promising template for the development of next-generation antibacterial agents to combat the growing crisis of AMR.
Keywords: Pyrimidine, Antibacterial agents, Structure-Activity Relationship (SAR), AMR.
Download PDF